Now showing items 1-1 of 1

    • Late recurrence in ER+ breast cancer - refining risk prediction beyond 5 years 

      Dowsett, M; Richman, J (Institute of Cancer Research (University Of London), 2021-11-30)
      ER positive (ER+) breast cancer has the potential to recur many years following diagnosis. Predicting who is most at risk of recurrence and when this may occur is complex. Risk prediction incorporates clinical, pathological ...